Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
Cert. of designation
Director departure
Asset disposition
Notes underwriting agrmnt

Rennova Health, Inc. (RNVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS",
"Speakers: Kevin Davis and Seamus Lagan"
08/15/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/16/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/15/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/09/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/24/2023 8-K Quarterly results
04/17/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. PROVIDES UPDATE ON 2022 FINANCIALS AND MYRTLE RECOVERY CENTERS WEST PALM BEACH, Fla. – Rennova Health, Inc. Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on 2022 financial statements and other activities.",
"Rennova Health, Inc. Interview CEO Seamus Lagan on Uptick Newswire – February 2023 Speakers: Everett Jolly and Seamus Lagan"
12/30/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
11/23/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/20/2022 8-K Quarterly results
09/23/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
09/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. PROVIDES BUSINESS UPDATE WEST PALM BEACH, Fla. – Rennova Health, Inc. Chief Executive Officer Seamus Lagan joined Stock Day host Everett Jolly to provide an update on the business and future plans.",
"RENNOVA HEALTH INTERVIEW CEO SEAMUS LAGAN ON UPTICK NEWSWIRE SEPTEMBER 2022"
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
06/16/2022 8-K Quarterly results
05/23/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/27/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. DISCUSSES 2021 FINANCIAL RESULTS AND COMPANY PROGRESS WITH THE STOCK DAY PODCAST WEST PALM BEACH, Fla. – Rennova Health, Inc. Chief Executive Officer Seamus Lagan joined Stock Day host Everett Jolly to discuss its 2021 financial results and provide an update on the business.",
"Rennova Health Interview CEO Seamus Lagan on Uptick Newswire April 2022"
04/15/2022 10-K Annual Report for the period ended December 31, 2021
04/07/2022 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
04/07/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
03/31/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/17/2022 D Form D - Notice of Exempt Offering of Securities:
03/16/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. – Rennova Health, Inc. , today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 , the Company completed a 1 for 10,000 reverse stock split of its outstanding common stock. The Company’ s common stock will open for trading on Wednesday March 16, 2022, on a post-split basis and trade under the symbol RNVAD for 20 days. As a result of the reverse stock split, every 10,000 shares of the Company’ s common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share, except to the extent that the reverse stock split results in any of the Company’ s stockholders owning a fractional share, which fractional share will be in that case paid in cash. In connecti..."
03/10/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/01/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of January 31, 2022, between Rennova Health, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4 of the Securities Act , and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and..."
12/17/2021 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
12/17/2021 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
12/16/2021 DEF 14C Form DEF 14C - Other definitive information statements:
12/13/2021 8-K Quarterly results
11/26/2021 PRE 14C Form PRE 14C - Other preliminary information statements:
11/15/2021 10-Q Quarterly Report for the period ended September 30, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy